JP2015512247A5 - - Google Patents

Download PDF

Info

Publication number
JP2015512247A5
JP2015512247A5 JP2015500780A JP2015500780A JP2015512247A5 JP 2015512247 A5 JP2015512247 A5 JP 2015512247A5 JP 2015500780 A JP2015500780 A JP 2015500780A JP 2015500780 A JP2015500780 A JP 2015500780A JP 2015512247 A5 JP2015512247 A5 JP 2015512247A5
Authority
JP
Japan
Prior art keywords
scfv
compound
snap
receptors
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015500780A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015512247A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/055022 external-priority patent/WO2013139391A1/en
Publication of JP2015512247A publication Critical patent/JP2015512247A/ja
Publication of JP2015512247A5 publication Critical patent/JP2015512247A5/ja
Pending legal-status Critical Current

Links

JP2015500780A 2012-03-21 2012-03-21 光線力学的療法に使用するための新規光免疫複合体 Pending JP2015512247A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/055022 WO2013139391A1 (en) 2012-03-21 2012-03-21 Novel photoimmunoconjugates for use in photodynamic therapy

Publications (2)

Publication Number Publication Date
JP2015512247A JP2015512247A (ja) 2015-04-27
JP2015512247A5 true JP2015512247A5 (enExample) 2015-06-11

Family

ID=45855805

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015500780A Pending JP2015512247A (ja) 2012-03-21 2012-03-21 光線力学的療法に使用するための新規光免疫複合体

Country Status (8)

Country Link
US (1) US9872904B2 (enExample)
EP (1) EP2827906A1 (enExample)
JP (1) JP2015512247A (enExample)
KR (1) KR20150003719A (enExample)
CN (1) CN104203286B (enExample)
CA (1) CA2866933C (enExample)
IN (1) IN2014DN06866A (enExample)
WO (1) WO2013139391A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8524239B2 (en) 2010-07-09 2013-09-03 The United States of America as represented by the Secrectary, Department of Health and Human Services Photosensitizing antibody-fluorophore conjugates
ES2743458T5 (es) 2014-08-08 2023-06-08 Us Health Eliminación fotocontrolada de dianas in vitro e in vivo
WO2016202365A1 (en) * 2015-06-16 2016-12-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Specific photoimmuno-theranostics for detection and elimination of skin cancer cells
EP3331909A1 (en) 2015-08-07 2018-06-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Near infrared photoimmunotherapy (nir-pit) of suppressor cells to treat cancer
EP3827846B1 (en) 2015-08-18 2024-10-02 Rakuten Medical, Inc. Compositions, combinations and related methods for photoimmunotherapy
CN114699525A (zh) 2015-08-18 2022-07-05 乐天医药生技股份有限公司 酞菁染料偶联物的制造方法及稳定偶联物
KR102061322B1 (ko) 2017-03-21 2019-12-31 한국과학기술원 항-cd25 단일클론 항체-광감각제 복합체를 포함하는 암 예방 또는 치료용 약학 조성물
WO2019126144A1 (en) 2017-12-22 2019-06-27 North Carolina State University Polymeric fluorophores, compositions comprising the same, and methods of preparing and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221001B1 (hu) 1994-03-17 2002-07-29 Merck Patent Gmbh. Egyláncú anti-EGFR Fv-k és anti-EGFR ellenanyagok
ZA952174B (en) * 1994-03-17 1995-12-27 Merck Patent Gmbh Anti-EGFR single-chain fvs and anti-EGFR antibodies
US6936469B2 (en) 2001-03-22 2005-08-30 Chromos Molecular Systems Inc. Methods for delivering nucleic acid molecules into cells and assessment thereof
AU2004205898B2 (en) 2003-01-17 2009-11-19 The Research Foundation Of State University Of New York Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
EP1882688A1 (en) * 2006-07-25 2008-01-30 EPFL Ecole Polytechnique Fédérale de Lausanne Labelling of fusion proteins with synthetic probes
CA2693155A1 (en) * 2007-07-25 2009-01-29 Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Self coupling recombinant antibody fusion proteins

Similar Documents

Publication Publication Date Title
JP2015512247A5 (enExample)
JP7076152B2 (ja) IgG結合ペプチドによる抗体の特異的修飾
JP2022065174A5 (enExample)
JP2020114828A5 (enExample)
JP7291395B2 (ja) IgG結合ペプチド、及び該ペプチドによる抗体の特異的修飾
JP6105479B2 (ja) 血清アルブミンに結合する設計リピートタンパク質
US20200093933A1 (en) Binding protein drug conjugates comprising anthracycline derivatives
Hong et al. Chemoenzymatic Synthesis of a Rhamnose‐Functionalized Bispecific Nanobody as a Bispecific Antibody Mimic for Cancer Immunotherapy
JP2019522490A5 (enExample)
CN114867754A (zh) 多价和多特异性纳米颗粒平台和方法
RU2017144606A (ru) Иммуноцитокины на основе il-15 и il-15rа домена sushi
EA200800696A1 (ru) Полипептиды и антитела
JP2016525551A5 (enExample)
JP2007526880A5 (enExample)
RU2014120536A (ru) Белки специфического связывания и их применения
JP2012500006A5 (enExample)
EA021967B1 (ru) Доставка антител посредством модульного домена распознавания
RU2015152077A (ru) Тримерные антигенсвязывающие молекулы
CN111971060A (zh) 募集抗体并靶向肿瘤细胞的双功能分子
JP2019511201A5 (enExample)
JP2020500885A5 (enExample)
JP2018530331A5 (enExample)
Van Fossen et al. Nanobody assemblies with fully flexible topology enabled by genetically encoded tetrazine amino acids
JP2015520172A5 (enExample)
JPWO2020206330A5 (enExample)